Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-Label, Comparative, Multi-Center Study Of Voriconazole Compared To Itraconazole For The Primary Prophylaxis Of Invasive Fungal Infection (IFI) With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

NCT00289991 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00289991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-Label, Comparative, Multi-Center Study Of Voriconazole Compared To Itraconazole For The Primary Prophylaxis Of Invasive Fungal Infection (IFI) With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
February 28, 2009
Enrollment
489 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

antifungal prophylaxis of invasive fungal infections